Quick Answer
Compounding can solve a real patient-specific problem, but it does not create an FDA-approved drug. Peptides add quality, sterility, concentration, and measurement risks.
What This Helps You Do
- Know when compounding is a medical workaround versus a marketing shortcut.
- Ask the pharmacy and concentration questions that change safety risk.
- Understand why compounded GLP-1 dosing errors became a major warning.
Compounding can meet a real medical need when an approved product cannot serve a particular patient. But compounded drugs are not FDA-approved, and they do not receive FDA premarket review for safety, effectiveness, or quality.
For peptide products, concentration and route can be especially important. FDA has warned about dosing errors with compounded injectable semaglutide, including errors tied to units, milligrams, milliliters, syringe size, and variable concentrations.
If a clinician recommends a compounded peptide, ask why an approved product does not meet the need, which pharmacy is used, whether sterile standards apply, and how the exact concentration is documented.
Where compounding fits
Compounding can be valuable when a patient has a legitimate need that an approved product cannot meet, such as a specific allergy, dosage form issue, or shortage context.
But compounding is not a shortcut around evidence. A compounded drug is not FDA-approved and does not receive the same premarket review as an approved product.
Why peptides are tricky
Peptides can be sensitive to concentration, storage, sterility, route, and impurities. A small labeling or measurement problem can become a significant safety problem.
FDA has specifically warned about dosing errors with compounded injectable semaglutide, including confusion between units, milliliters, and milligrams.
Questions worth asking
Ask why an approved product is not suitable, which pharmacy is compounding it, whether sterile compounding standards apply, what certificate or quality information is available, and how the exact concentration is communicated.
If the answer is vague, promotional, or rushed, that is useful information too.
Red Flags
- The only reason given is cheaper or easier access.
- The concentration is unclear or differs between refills.
- Patients are expected to translate units, milliliters, and milligrams without training.
Questions To Ask
- Why is an approved product not suitable?
- Which licensed pharmacy or outsourcing facility is making it?
- What sterile standards, concentration, beyond-use date, and syringe instructions apply?
Source Checkpoints
Use these official or clinical references to verify the category, claim, or safety concern before acting on marketing copy.